Showing results (891-900 of 933) with videos related to

Sort By:
Pageof 94
The Journal of Biological Chemistry|March 30, 2001
Akt participation in the Wnt signaling pathway through DishevelledS Fukumoto, C M Hsieh, K Maemura, et al.
Environmental Health Perspectives|March 21, 2007
Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, NevadaKaren K Steinberg, Mary V Relling, Margaret L Gallagher, et al.
Clinical and Translational Allergy|July 18, 2022
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)Stanley J Szefler, Graham Roberts, Adalberto S Rubin, et al.
Joint Commission Journal on Quality and Patient Safety|December 12, 2018
Leveraging Quality Improvement Science to Reduce C. difficile Infections in a Community HospitalBarbara B Lambl, Sarah Altamimi, Nathan E Kaufman, et al.
Plastic and Reconstructive Surgery|March 1, 2012
Parameters of care for craniosynostosis: craniofacial and neurologic surgery perspectivesStephen M Warren, Mark R Proctor, Scott P Bartlett, et al.
The Journal of Biological Chemistry|October 11, 1996
The v-Ki-Ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase IIbetaA Feliciello, P Giuliano, A Porcellini, et al.
The Western Journal of Emergency Medicine|March 30, 2022
Emergency Department-initiated High-flow Nasal Cannula for COVID-19 Respiratory DistressZachary J Jarou, David G Beiser, Willard W Sharp, et al.
Thorax|November 15, 2005
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsS Yende, G W Waterer, E A Tolley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
The Journal of Clinical Investigation|February 16, 2008
Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressureWan-Heng Wang, Loretta G McNatt, Iok-Hou Pang, et al.
Pageof 94